The results were supported with a bioinformatic assessment, revealing genome-, epigenome-, and proteome-wide effects of C19orf53 polymorphisms as well as an established link between SNPs in the C19orf53 gene and cerebrovascular disease-related phenotypes. This evidence concerns the gene C19orf53 and cerebrovascular disorder.